Patent · US Active

Compositions for treating retinal degeneration and methods of production and use thereof

US10258613B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

The Board of Regents of the University of Oklahoma · US

Inventors

Xi DING · Edmond, US
Hongwei Ma · Beijing, CN

Key dates

Filing date	Feb 5, 2015
Grant date	Apr 16, 2019
Priority date	—
Expiry date	Feb 8, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/495
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions for use in methods of treating and/or inhibiting a pathologic ocular condition, as well as methods of producing and using same, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.